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Abstract 
Background: The use of methotrexate (MTX) by systemic administration i  the treatment of unruptured ectopic pregnancy has 
been reported as a safe and effective method. Cases: We report three cases (one hematosalpinx and two pelvic hematocoeles) of 
complications after the use of MTX in the treatment of unruptured ectopic pregnancies. All three cases came to our observation 
for pelvic pain, abnormal bleeding and a pelvic mass after an interval of 3-5 months, subsequent to the disappearance of
symptoms and normalization of serum human chorionic gonadotropin fl-subunit (fl-hCG) levels. Conclusions: These findings 
suggest hat: (a) such complications should be considered before selecting the mode of treatment for ectopic pregnancy; and (b) 
that an early ultrasonographic control should be performed after MTX treatment even when the decline in fl-hCG levels suggests 
a successful resolution. This would permit an early diagnosis of these late complications. Copyright © 1996 Elsevier Science 
Ireland Ltd 
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1. Introduction 
In the past decade the management of ectopic preg- 
nancy has changed significantly. This is largely due to 
the capability to diagnose the condition early by using 
serial serum fl-hCG measurements and transvaginal 
ultrasonography. Early diagnosis has also permitted a 
wider utilization of conservative treatment. While a 
laparoscopic conservative surgical approach is the most 
widely adopted treatment modality, systemic adminis- 
tration of methotrexate (MTX) is being increasingly 
used in unruptured ectopic pregnancies. Several studies 
have reported the effectiveness and safety of MTX 
treatment [1-3], but this approach is not completely 
free of complications [4 6]. 
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The purpose of this paper is to report three cases of 
long term complications following MTX treatment of 
ectopic pregnancy. 
2. Case reports 
2. I. Case 1 
A 28 year old woman with a 3 years history of 
infertility was referred to our service because of a 
retrouterine pelvic mass diagnosed ultrasonographi- 
cally. This 8 cm mass showed a dishomogeneous echo- 
genic pattern. The patient's only current complaint was 
of mild pelvic pain. Six months earlier she had been 
found to have an unruptured right tubal pregnancy 
(with no fluid in the pouch of Douglas) by US. Her 
f l-hCG level was 1.870 mlU/ml. She had been treated 
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in a peripheral hospital with a single dose of MTX 50 
mg/m 2 [7]. The serum /]-hCG levels were monitored 
subsequently and declined to less than 5.0 mIU/ml over 
a span of 4 weeks and she was completely symptoms-free. 
We performed a laparoscopy which demonstrated a large 
retrouterine pelvic hematocoele involving both tubes and 
ovaries. These structures were carefully dissected free 
and all visceral adhesions were removed. Clots were 
aspirated by means of a 10 mm cannula. Subsequent 
chromopertubation revealed occlusion of the right tube 
at the level of the ampulla and a right salpingectomy was 
performed. The histopathologic examination of capsula 
and content of the mass revealed blood clots with 
hemosiderin and an organized classic inflammatory and 
fibrous capsule. 
2.2. Case 2 
A 26 year old woman with secundary infertility of 4 
years duration was referred to our service because of 
abnormal vaginal bleeding, pelvic pain and a pelvic mass. 
Four months before she had been treated elsewhere by 
means of a course of MTX and citrovorum factor for an 
unruptured ectopic pregnancy in the left tube ultrasono- 
graphically diagnosed without any other abnormal pelvic 
finding (6 weeks and 5 days gestational age; /]-hCG 
serum level of 1015 mIU/ml). The treatment schedule 
was: MTX (1 mg/kg body weight) alternating with folinic 
acid (0.1 mg/kg) both administrated intramuscularly on 
a daily basis and each for four doses. The serum fl-hCG 
level had dropped to less than 10 mIU/ml in 4 weeks. 
At laparoscopy, performed for the investigation of the 
mass, a large hematosalpinx was found in a pelvis 
completely obliterated by adhesions. After extensive 
adhesiolysis the left tube was laparoscopically removed. 
The histopathological examination confirmed the diag- 
nosis of hematosalpinx. 
2.3. Case 3 
A 32 year old woman with a 5 years primary infertility 
came back to our service complaining of pelvic pain and 
irregular menstruations. Her WBC count was 12 000/mc 
and the ultrasonographic findings were suggestive of a 
pelvic abscess. Four months earlier, we had treated her 
with a single i.m. dose of 50 mg of MTX for an 
unruptured ectopic pregnancy, diagnosed by means of 
transvaginal ultrasonography. The initial serum/)'-hCG 
level was 1500 mIU/ml and had declined to less than 5 
mIU/ml in 4 weeks with the disappearance of any 
symptom. At readmission the ultrasonographic 
examination showed a complex retrouterine mass of 
about 10 cm in diameter. 
The laparoscopic examination revealed a pelvic 
hematocoele, and the mass, composed of blood clots and 
of an external capsule, was completely removed. 
3. Discussion 
These three cases demonstrate the possibility of long 
term silent complications associated with MTX treat- 
ment of ectopic pregnancy. This type of treatment, 
notwithstanding the relevant reports of safety and effec- 
tiveness [1 3], should still be considered experimental in
cases of ectopic pregnancy associated with a serum 
fl-hCG level greater than 1000 mIU/ml. 
The occurrence of tubal damage after MTX treatment 
has been described before [4,5]. However, at present, the 
real incidence of reproductive impairment after this type 
of treatment is still unknown. Stovall et al. [3] reported 
a relatively low incidence of tubal blockage at hys- 
terosalpingography. However, a pelvic hematocoele may 
occur notwithstanding open tubes at hysterosalpingogra- 
phy. Therefore, adverse effects and complications of 
MTX treatment of ectopic pregnancy, such as he- 
matosalpinx and pelvic hematocoele, should be taken 
into account when considering medical versus surgical 
treatment of the condition [8], and further studies are 
needed to evaluate the exact incidence. Furthermore, we 
suggest hat an early ultrasormgraphic control should be 
performed in all patients treated with MTX with an 
apparently successful result at the time of/~'-hCG disap- 
pearance and 1 month later, to permit an early diagnosis 
of these complications. 
We conclude that the actual incidence of such compli- 
cations should be correctly evaluated in a large multicen- 
ter prospective trial of systemic MTX in the treatment 
of ectopic pregnancy. Meanwhile, an early ultrasono- 
graphic control is highly advisable after MTX treatment, 
even when the decline in serum [)'-hCG levels suggests a
successful resolution. 
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